Yutopar S.R en es it fr

Yutopar S.R Brand names, Yutopar S.R Analogs

Yutopar S.R Brand Names Mixture

  • No information avaliable

Yutopar S.R Chemical_Formula

C17H21NO3

Yutopar S.R RX_link

No information avaliable

Yutopar S.R fda sheet

Yutopar S.R msds (material safety sheet)

Yutopar_S.R MSDS

Yutopar S.R Synthesis Reference

Belg. pat. 660.244 (1965 to N.V. Philips), C.A. 63, 17965h (1965) corresp to Claassen et al., U.S. pat. 3,410,944 (1968 to No. Am. Philips)

Yutopar S.R Molecular Weight

287.354 g/mol

Yutopar S.R Melting Point

88-90 oC

Yutopar S.R H2O Solubility

Complete

Yutopar S.R State

Solid

Yutopar S.R LogP

2.588

Yutopar S.R Dosage Forms

Solution for IV; Capsule (extended-release); Tablet; Intramuscular injection

Yutopar S.R Indication

For the treatment and prophylaxis of premature labour

Yutopar S.R Pharmacology

Beta-2 adrenergic receptors are located at sympathetic neuroeffector junctions of many organs, including uterus. Ritodrine is beta-2 adrenergic agonist. It stimulates beta-2 adrenergic receptor, increases cAMP level and decreases intracellular calcium concentration. The decrease of calcium concentration leads to a relaxation of uterine smooth muscle.

Yutopar S.R Absorption

No information avaliable

Yutopar S.R side effects and Toxicity

LD50=64mg/kg (mice, IV); LD50=540 mg/kg (mice, oral); LD50=85 mg/kg (rat, IV)

Yutopar S.R Patient Information

Yutopar S.R Organisms Affected

Humans and other mammals